Editorial Advisory Board -- Chairperson
Jeff Andrews, MD -- Associate Professor of Medical Education, Associate Professor of OB/GYN, & Senior Fellow, Vanderbilt Center for Evidence-Based Medicine, Vanderbilt University

Dr. Jeff Andrews has appointments as associate professor of medical education, associate professor of OB/GYN, and is senior fellow of the Vanderbilt Center for Evidence-Based Medicine. In conjunction with the VCEBM, Dr. Andrews is participating in the integration of evidence-based medicine with clinical orders and pathways in clinical care; expansion of EBM within the curriculum; and applied EBM research. Dr. Andrews served as vice president and then as chief medical officer for EBM Solutions, creating evidence-based guidelines and tools for use by providers and patients on the Internet. Before Vanderbilt, Dr. Andrews spent 11 years at Duke University Medical Center. His leadership roles at Duke included associate professor, division chief, medical director of women's services, medical director of OB/GYN quality improvement and performance improvement, medical director of DukeHealth Internet initiative, and clinical advisor for evidence-based medicine guidelines. Prior to joining Duke University Medical Center, Dr. Andrews practiced in Canada for five years. Dr. Andrews completed his internship and residency in Obstetrics and Gynecology at the University of Toronto. Dr. Andrews received his medical degree from the University of Toronto in Toronto, Ontario, Canada. He is board certified by the Royal College of Physicians and Surgeons of Canada and is a fellow of the American College of Obstetricians and Gynecologists. Dr. Andrews is a member of numerous international organizations, including Cochrane Collaborative Review Groups, Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, Guidelines International Network (G-I-N), Society for Medical Decision Making, and Appraisal of Guidelines Research and Evaluation (AGREE).

Disclosures: Dr. Andrews has nothing to disclose.

Allan Gibofsky, MD, JD -- Professor of Medicine & Public Health, Weill Medical College of Cornell University

Dr. Allan Gibofsky is professor of medicine and public health at the Weill Medical College of Cornell University, professor of law at Fordham University and adjunct faculty at the Rockefeller University. He is an attending physician and rheumatologist at the Hospital for Special Surgery and New York-Presbyterian Hospital. Dr. Gibofsky has authored and co-authored numerous papers and text chapters, primarily on the immunogenetics of rheumatic diseases and legal aspects of medical practice. Dr. Gibofsky is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular for his basic and clinical studies on rheumatic fever. Dr. Gibofsky received his undergraduate degree from Brooklyn College of the City University of New York, his medical degree from Weill Medical College of Cornell University and his law degree from Fordham University. He completed his internship in pathology, followed by a residency in medicine at New York Hospital. Dr. Gibofsky completed a fellowship in Rheumatology/Immunology jointly at the Hospital for Special Surgery and The Rockefeller University.

Disclosures: Dr. Gibofsky has disclosed that he has served as a consultant and served on the speakers bureaus for Abbott, Amgen, Bristol-Myers Squibb, Wyeth and Pfizer.

Donald C. Goff, MD -- Director, Schizophrenia Program at Massachusetts General Hospital

Dr. Donald C. Goff is director of the schizophrenia program at Massachusetts General Hospital and associate professor of psychiatry at Harvard Medical School. In addition, he is medical director of the Freedom Trail Clinic at the Erich Lindemann Mental Health Center in Boston. Prior to his positions with Massachusetts General Hospital and Harvard Medical School, Dr. Goff was assistant professor of Psychiatry at Tufts School of Medicine. Dr. Goff completed his research fellowship in psychopharmacology at Tufts-New England Medical Center. He completed his residency in psychiatry at Massachusetts General Hospital and an internship in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Dr. Goff earned his medical degree from the University of California School of Medicine in Los Angeles and his undergraduate degree in humanities at the University of California in Berkeley.

Disclosures: Dr. Goff has disclosed he has received honoraria from Eli Lilly, Janssen, Pfizer and Bristol-Myers Squibb; research funding from Janssen, Pfizer, Cephalon and GlaxoSmithKline; and has served on the advisory boards for Janssen, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Merck.

William A. Grana, MD, MPH -- Professor, Department of Orthopaedic Surgery at The University Physicians Healthcare, University of Arizona College of Medicine

Dr. William A. Grana received his medical degree from Harvard University in 1968. He completed his residency at Barnes Hospital, Washington University, St. Louis in 1975 and a fellowship in sports medicine from the University of Oklahoma Health Sciences Center in 1976. He was board-certified in orthopaedic surgery in 1976. He received a master's degree in public health administration and policy from the University of Oklahoma in 1995. From 1975 to 2000, he was on the faculty of the University of Oklahoma College of Medicine, including clinical professor of orthopaedics and director of sports medicine. Dr. Grana was also an orthopaedic consultant to Oklahoma State University, Oklahoma City University and the Texas Ranger's AAA baseball team, the Oklahoma Redhawks. Nationally, he assumed the role of President for the American Orthopaedic Society for Sports Medicine for 2005/2006 and is the Editor-in-Chief for the American Academy of Orthopaedic Surgeons' educational Web site called Orthopaedic Knowledge Online. He is a consultant to the Chicago White Sox and a team physician for their Tucson training camps. He is also an orthopaedic consultant to the University of Arizona Athletic Department and regularly provides care to University of Arizona athletes. Dr. Grana's current professional interests include sports-related problems that affect the knee, shoulder, ankle and elbow. He is the author of more than 100 papers in refereed journals.

John D. Hainsworth, MD -- Chief Scientific Officer, Sarah Cannon Research Institute

As chief scientific officer for the Sarah Cannon Research Institute, Dr. John D. Hainsworth is responsible for the scientific progress of the SCRI, including protocol development, data analysis and manuscript preparation. Dr. Hainsworth has a variety of clinical research interests and has published extensively in the areas of lung cancer, unknown principal cancer, breast cancer and lymphoma. He has concentrated his research on expanded roles and innovative uses for several new drugs, including docetaxel, gemcitabine, rituximab and bevacizumab. Dr. Hainsworth received his medical degree from Vanderbilt University and his Bachelor of Arts degree from Stanford University.

Disclosures: Dr. Hainsworth disclosed he has received grant and research support from Genentech, Biogen Idec, Eli Lilly, Pfizer, Novartis and Amgen.

Ronald C. Hamdy, MD, FRCP, FACP -- Professor of Internal Medicine and holder of the Cecile Cox Quillen Chair of Excellence in Geriatric Medicine and Gerontology at East Tennessee State University

Dr. Ronald C. Hamdy is professor of internal medicine and holder of the Cecile Cox Quillen Chair of Excellence in Geriatric Medicine and Gerontology at East Tennessee State University. He is the director of the Osteoporosis Center at East Tennessee State University. He is also the editor-in-chief of the Southern Medical Journal. Dr. Hamdy is actively involved in research and practices in Johnson City, Tenn. He has published four books, more than 150 articles in medical journals, and numerous chapters in medical texts. Dr. Hamdy served as president of the Southern Medical Association in 1999-2000. In 1985, he was recruited by East Tennessee State University. Prior to joining East Tennessee University, Dr. Hamdy was senior lecturer and consultant in medicine at the University of London, England. Dr. Hamdy completed his postgraduate training at the University of London, England.

Disclosures: Dr. Hamdy disclosed he has received grant and research support from Procter & Gamble and Aventis and has served as a consultant and served on the speakers bureaus for Merck, Procter & Gamble, Novartis and Eli Lilly.

Andra H. James, MD, MPH -- Assistant Professor of Obstetrics & Gynecology, Division of Maternal Fetal Medicine, Duke University Medical Center

Dr. Andra H. James is a maternal-fetal medicine specialist and an assistant professor in the department of obstetrics and gynecology at the Duke University Medical Center. She is a co-director of Duke's Comprehensive Hemostasis and Thrombosis Center and founder of the Women's Hemostasis and Thrombosis Clinic. Her practice, research and publications pertain to reproductive issues among women with bleeding and clotting disorders. She has served on the U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute's Women with Bleeding Disorders Working Group and on its von Willebrand Disease Expert Panel. Dr. James previously served as a nurse at the University of Rochester and as a nurse-midwife at Johns Hopkins University, where she earned her master's degree in public health. She attended medical school at the University of Virginia and trained in obstetrics and gynecology at the University of North Carolina. Dr. James went to Duke University as a fellow in maternal-fetal medicine.

Disclosures: Dr. James has disclosed she has received grant and research support from CSL Behring.

James W. Jefferson, MD -- Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health

Dr. James W. Jefferson is a clinical professor of psychiatry at the University of Wisconsin School of Medicine and Public Health. In addition, he is co-founder of the Lithium Information Center, Bipolar Disorders Treatment Information Center and Obsessive Compulsive Information Center and director of Healthcare Technology Systems. He joined the faculty at University of Wisconsin in 1974, was tenured in 1978, served as professor of psychiatry from 1981 to 1992 and as director of the Center for Affective Disorders from 1983 to 1992. Between 1992 and 1998, Dr. Jefferson served as a Distinguished Senior Scientist at the Dean Foundation for Health, Research and Education. In 1998, he became a Distinguished Senior Scientist at the Madison Institute of Medicine. His major clinical and research interests are in mood and anxiety disorders, psychopharmacology and the medical/psychiatry interface. Dr. Jefferson completed his residency in psychiatry at the University of Wisconsin after serving with the military as a research cardiologist. He completed his residency in internal medicine at the University of Wisconsin, a cardiology fellowship at the University of Chicago and a medical internship at St. Luke's Hospital in New York. Dr. Jefferson received his medical degree from the University of Wisconsin.

Disclosures: Dr. Jefferson has disclosed he has received grant/research support from Bristol-Myers Squibb, Forest, GlaxoSmithKline, Janssen, Eli Lilly, Novartis, Organon, Pfizer, Roche, Solvay, UCB Pharma, and Wyeth. He also disclosed that he has served as a consultant to GlaxoSmithKline, Schwarz, Shire, and Organon and has received lecture honoraria from Abbott, AstraZeneca, Bristol-Myers Squibb, Forest, GlaxoSmithKline, Eli Lilly, Pfizer, Schwarz, Shire, and Wyeth. He is a stock shareholder in Bristol-Myers Squibb, GlaxoSmithKline, and SciClone and is the principal of Healthcare Technology Systems Inc.

David Johnson, MD -- Cornelius Abernathy Craig Professor in Medical and Surgical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center

Dr. David H. Johnson is the Cornelius Abernathy Craig Professor in Medical and Surgical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center. He graduated from the Medical College of Georgia in 1976, joined the Vanderbilt faculty upon completion of his oncology fellowship in 1983 and was appointed Director of the Division of Hematology and Medical Oncology in 1991. He is a board-certified internist and medical oncologist, a widely recognized investigator in the fields of lung and breast cancer, the author of over 300 publications, editor or co-editor of numerous oncology textbooks and serves on the editorial boards of numerous internal medicine and cancer journals. In 2004/2005, Dr. Johnson served as the 41st President of the American Society of Clinical Oncology (ASCO), the world's largest organization of cancer specialists. Currently, he is a member of the Boards of Directors of the American Board of Internal Medicine (ABIM), the Lance Armstrong Foundation and the International Association for the Study of Lung Cancer. He is also chairman of the ABIM Oncology Subspecialty Certification Board. Dr. Johnson has been named to numerous “Best Doctor” lists over the past 25 years including Woodward & White's Best Doctors in America, Woodward & White's Best Cancer Doctors in America, America's Top Doctors, and Good Housekeeping magazine's list of the country's top oncologists for women. In 2006 he received the Southern Association of Oncology's Distinguished Oncologist Award, the Association of Community Cancer Centers Clinical Research Award in 2007 and the ASCO Statesman Award in 2008.
Disclosures: Dr. Johnson has nothing to disclose.

John P. Leonard, MD -- Chief, Lymphoma/Myeloma Service, Division of Hematology and Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York Weill Cornell Center; The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Professor of Medicine, Weill Medical College; Attending Physician, New York Presbyterian Hospital

Dr. John P. Leonard is chief of the Lymphoma/Myeloma Service in the Division of Hematology and Oncology at Weill Medical College of Cornell University, New York Presbyterian Hospital and New York Weill Cornell Center, as well as an attending physician at the New York Presbyterian Hospital and a professor of medicine at the Weill Medical College. He also serves as clinical director for the Cornell Center for Lymphoma and Myeloma in New York and director of the Hematology/Oncology Clinical Research Program at Weill Medical College. His research focuses on the development of novel immunotherapies and other translational strategies for lymphoma and other malignancies. Dr. Leonard served as chief resident in the department of medicine at New York Presbyterian Hospital, where he also received his internship, residency and fellowship training. Dr. Leonard performed his undergraduate work at Johns Hopkins University, and attended the University of Virginia School of Medicine.

Disclosures: Dr. Leonard has disclosed he has received honoraria from and has served as a consultant to Genentech, Biogen Idec, GlaxoSmithKline, Millennium Pharmaceuticals, Celgene, Cougar Biotechnology, Eisai, Astellas Pharma and Novartis.

David J. Maron, MD, FACC -- Associate Professor of Medicine & Emergency Medicine, Vanderbilt University, Director, Vanderbilt Chest Pain Center, Medical Director, Dayani Health & Wellness Center

Dr. David J. Maron received his bachelor's degree from Stanford University and his medical degree from the University of Southern California School of Medicine in 1981. He completed his residency at the University of California, Los Angeles Medical Center in 1984. He was a Robert Wood Johnson Clinical Scholar and cardiology fellow at Stanford University. He is board-certified in internal medicine and in cardiovascular diseases. Dr. Maron's patient care and clinical research emphasis at Vanderbilt is preventive cardiology, lipid disorders and ischemic heart disease.

David N. Neubauer, MD -- Associate Director, Johns Hopkins Sleep Disorders Center

Dr. David N. Neubauer is associate director of the Johns Hopkins Sleep Disorders Center and an assistant professor in the department of psychiatry at the Johns Hopkins University School of Medicine. Dr. Neubauer is also the medical director of the Psychiatry Mobile Treatment Program at the Johns Hopkins Bayview Medical Center. He earned his bachelor's and master's degrees at Florida Atlantic University. He earned his medical degree at the University of Miami School of Medicine, and completed his psychiatry internship and general psychiatry residency at Johns Hopkins Hospital.

Disclosures: Dr. Neubauer has disclosed he has served as a consultant and/or has received lecture fees from Neurocrine Biosciences, Pfizer, Sanofi-Aventis and Takeda Pharmaceuticals.

Michelle Petri, MD, MPH -- Professor of Rheumatology, Johns Hopkins University

Dr. Michelle Petri is a professor in the division of rheumatology within the department of medicine at Johns Hopkins University and is co-director of the Hopkins Lupus Pregnancy Center. Her main research interests are the various aspects of lupus, including thrombotic events, antiphospholipid antibodies, coronary artery disease, pregnancy loss and preterm birth, health status, measurement of lupus disease activity, longitudinal study of the predictive value of complement split products as laboratory measure of disease in lupus and avascular of bone. She is a member of the American College of Rheumatology, participates on the Medical Advisory Board of the Lupus Foundation of America and serves as the Chair of the Lupus Now Education Program. Also, she serves on the editorial boards of Journal of Rheumatology, Journal of Clinical Rheumatology and Lupus, and is an ad hoc reviewer for Annals of Internal Medicine, American Journal of Medicine, Medicine, the Lancet, the Journal of the American Medical Association, Southern Medical Journal and Fertility and Sterility. Dr. Petri earned her MPH at Johns Hopkins University School of Hygiene and Public Health, Epidemiology and her medical degree from Harvard Medical School. She completed an internship and her residency at Massachusetts General Hospital, and a post-doctoral fellowship in allergy and immunology/rheumatology at the University of California, San Francisco.

Disclosures: Dr. Petri has disclosed she has received grant/research support from Zymogenetics, Pfizer, Genentech, MedImmune, UCB Pharma, Aspreva, Immunomedics, Teva Pharmaceuticals, Bristol-Myers Squibb, Forest and HGS. She also disclosed she has served as a consultant to Amgen, Centocor, Genelabs and was formerly on the speakers bureau for Genentech.

Stephen R. Pliszka, MD -- Deputy Chairman and Chief of the Adolescent Psychiatry Division, University of Texas Health Science Center at San Antonio

Dr. Steven R. Pliszka is the deputy chairman and chief of the Adolescent Psychiatry Division at the University of Texas Health Science Center at San Antonio (UTHSCSA). His primary research interests include neuroimaging in ADHD, clinical trials of new drugs in ADHD and related conditions, psychopharmacology of mental retardation and developmental disabilities. Dr. Pliszka earned his graduate and medical degrees at UTHSCSA, which is where he also completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry.

Disclosures: Dr. Pliszka has disclosed he has received grant/research support from Eli Lilly and AstraZeneca. He also disclosed he has served as a consultant to McNeil Pediatrics and Shire and has served on the speakers bureau for McNeil Pediatrics.

Kimberly Rask, MD, PhD -- Director, Emory Center on Health Outcomes and Quality; Associate Professor of Health Policy and Management, Rollins School of Public Health and Emory University School of Medicine

Dr. Kimberly Rask directs the Emory Center on Health Outcomes and Quality and is associate professor of health policy and management with joint appointments in the Rollins School of Public Health and the Emory University School of Medicine. Dr. Rask is a clinically active general internist and has served as clinical advisor and editor-in-chief to an academic medical center consortium developing Web accessible evidence-based clinical practice guidelines. Her research focuses on health promotion and outcomes measurement. She has published book chapters and peer-reviewed articles on primary care practice, cost-effectiveness, performance improvement and outcomes measurement. Her current research projects include: evaluating the cost-effectiveness of behavioral interventions to prevent the transmission of HIV infections; evaluating the use of Web accessible clinical practice guidelines in primary care practices; improving health outcomes for patients with diabetes in primary care settings; and evaluating the use of a pharmacy IT system to identify hospitalized patients at risk for adverse events. Dr. Rask received her doctorate in health economics from the Wharton School of the University of Pennsylvania and her medical training at the University of Pennsylvania. She is a fellow of the American College of Physicians.

Disclosures: Dr. Rask has nothing to disclose.

Moses Rodriguez, MD -- Professor of Neurology and Immunology, Mayo Medical School and Graduate School, Rochester, Minnesota

Dr. Moses Rodriguez is a professor of neurology and immunology at Mayo Medical School and Graduate School in Rochester, Minn. He is also the Mildred A. and Henry Uihlein Professor of Medical Research, and has served as chair of the Division of Demyelinating Diseases at Mayo and director of a program project entitled The Immunogenetics of Demyelination. From 1994 to 2007, Dr. Rodriguez directed the MD/PhD program at Mayo Medical School. He plays a very active role in mentoring graduate students and postdoctoral fellows to ensure continued vitality in the field of multiple sclerosis. Over the course of his career, Dr. Rodriguez has made significant contributions to the understanding of the pathogenesis of demyelination and of methods to enhance central nervous system repair. He received his undergraduate and graduate medical education at Northwestern University, and completed his residency training in internal medicine and neurology at the Mayo Graduate School of Medicine. As a National Institute of Health Trainee, he was a neuropathology fellow at the University of California at San Diego and at Scripps Clinic and Research Foundation.

Disclosures: Dr. Rodriguez has nothing to disclose.

Todd Schwedt, MD -- Assistant Professor of Neurology, Director of the Washington Headache Center, Washington University School of Medicine, St. Louis

Dr. Todd Schwedt specializes in the treatment and study of headache disorders. His research interests include headache and intracranial aneurysms, thunderclap headaches and reversible cerebral vasoconstriction, right-to-left shunt and migraine, objective measures of studying pain outcomes, and migraine-associated dizziness. Dr. Schwedt obtained his medical degree from the University of Missouri School of Medicine. He completed his medical internship and neurology residency at The Cleveland Clinic Foundation as well as a headache fellowship at Mayo Clinic.

Disclosures: Dr. Schwedt has disclosed he has received grant and research support from GlaxoSmithKline, AGA Medical, Allergan and the National Institutes of Health.

Stuart Silverman, MD, FACP, FACR -- Clinical Professor of Medicine, University of California at Los Angeles

Dr. Stuart Silverman is a clinical professor of medicine and rheumatology at the University of California at Los Angeles and Cedars Sinai Medical Center. He has served as acting chief of rheumatology at Greater Los Angeles VA Medical Center where he currently holds a research appointment. In His clinical practice he sees rheumatology patients and has a special interest in fibromyalgia, chronic fatigure, myofascial pain syndromes and osteoporosis. He also serves as the medical director of the Osteoporosis Medical Center's Clinical Research Center. Dr. Silverman is a member of the council of scientific advisors of the International Osteoporosis Foundation, a scientific advisor to the National Osteoporosis Foundation. He has served on a WHO task force for fracture assessment and is currently US project director for ICUROS, a global study on the cost and disutility of osteoporotic fracture. Dr. Silverman graduated from Princeton University in biology with an interest in art history. He received his medical degree from Johns Hopkins University. He was an intern and resident in the Boston University Hospital system and was a rheumatology fellow at Boston University under Dr. Alan Cohen. Following his rheumatology fellowship, he was a Thorndike research fellow. He is board certified in internal medicine, rheumatology and allergy-immunology.

Disclosures: Dr. Silverman has disclosed he has received research support from Eli Lilly, Wyeth, Roche, Procter & Gamble, Merck and Novartis. He also disclosed he has served as a consultant to Merck, Wyeth, Roche, Procter & Gamble and Novartis and has served on the speakers bureaus for Eli Lilly, Merck, Procter & Gamble and Roche.

Gary W. Small, MD -- Director, UCLA Center on Aging

Dr. Gary W. Small is director of the Aging and Memory Research Center at the Semel Institute for Neuroscience and Behavior and director of the UCLA Center on Aging as well as the Parlow-Solomon Professor on Aging. His other UCLA positions include professor of psychiatry and biobehavioral sciences; director of the geriatric psychiatry and psychology training program; and director of the imaging and genetics core of the Alzheimer's Disease Center. His research has focused on assessment and treatment of mental disorders of aging and emphasizes early detection and prevention of Alzheimer's disease using neuroimaging and genetic measures. Dr. Small completed a general psychiatry residency at Massachusetts General Hospital and Harvard Medical School, and a geriatric psychiatry fellowship at UCLA after receiving his medical degree from the University of Southern California and completing undergraduate work at UCLA.

Disclosures: Dr. Small has disclosed he has served as a consultant and/or has received lecture fees from Abbott, Dakim, Eisai, Forest, Myriad, Novartis, Ortho-McNeil, Pfizer, Radica Games, Servier, and Siemens. He also disclosed he has received stock options from Dakim and was co-inventor of FDDNP-PET, which UCLA has licensed to Siemens.

Thomas J. Weber, MD -- Assistant Professor of Medicine, Division of Endocrinology, Metabolism & Nutrition; Assistant Professor, Department of Obstetrics and Gynecology at Duke University Medical Center

Dr. Thomas J. Weber serves as assistant professor of medicine in the division of endocrinology, metabolism and nutrition as well as assistant professor in the department of obstetrics and gynecology at Duke University Medical Center. As an andrologist in the division of endocrinology, metabolism and nutrition, Dr. Weber serves as a referral source for men with hypogonadism and presents didactic lectures to the division. Dr. Weber's primary research interest centers on osteoporosis. He also maintains an interest in metabolic bone disease and oversees the DEXA Scanning unit. He offers an optional two-week rotation in the Metabolic Bone Disease Clinic to gain experience with metabolic bone disease, including bone density measurements. Dr. Weber completed his residencies in endocrinology and metabolism at Duke University Medical Center and his residency in internal medicine at Yale-New Haven Hospital. Dr. Weber received his medical training at the University of Chicago-Pritzker School of Medicine.

Disclosures: Dr. Weber has disclosed he has received grant/research support from Novartis, Eli Lilly, Procter & Gamble and GlaxoSmithKline. He also disclosed he has served as a consultant to Auxilium, Abbott and QuatRx Pharmaceuticals and has served on the speakers bureau for Eli Lilly, Merck, Procter & Gamble, GlaxoSmithKline and Novartis.